| Report ID | 274709 |
| Drug Identification Number | 02139561 |
| Brand name | OXYTOCIN INJECTION, USP |
| Common or Proper name | OXYTOCIN INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | OXYTOCIN |
| Strength(s) | 10UNIT |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 1mL |
| ATC code | H01BB |
| ATC description | POSTERIOR PITUITARY LOBE HORMONES |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2026-01-07 |
| Estimated end date | 2026-01-19 |
| Actual end date | 2026-01-08 |
| Shortage status | Resolved |
| Updated date | 2026-01-09 |
| Company comments | Due to unforeseen circumstances we will encounter a backorder on our Oxytocin Injection, USP 10 USP units/mL, 1 mL Vial, effective January 7, 2026 until January 19, 2026. Once stock is available, allocations will be increased to 150% of historical monthly demand. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2026-01-09 | English | Compare |
| v9 | 2026-01-08 | French | Compare |
| v8 | 2026-01-08 | English | Compare |
| v7 | 2026-01-08 | English | Compare |
| v6 | 2026-01-02 | French | Compare |
| v5 | 2026-01-02 | English | Compare |
| v4 | 2025-12-19 | French | Compare |
| v3 | 2025-12-19 | English | Compare |
| v2 | 2025-12-19 | French | Compare |
| v1 | 2025-12-19 | English | Compare |
Showing 1 to 10 of 10